10.1002/chem.201904199
Chemistry - A European Journal
FULL PAPER
N1,N3-Bis[4′-{(10″,20″-bis(4-methylphenyl)-15″-
Keywords: Porphyrin arrays • Molecular tweezers •
Supramolecular • Cubane • Bicyclo[1.1.1]pentane
phenylporphyrin)-5″-yl}-phenyl]bicyclo[1.1.1]pentane-1,3-
dicarboxamides (51). Synthesized according to General
Procedure 5 using BCP 36 (23 mg, 0.042 mmol), [5-(4′,4′,5′,5′-
tetramethyl-1′,3′,2′-dioxaborolan-2′-yl)-10,20-bis(4′-
[1]
(a) T. Tanaka, A. Osuka, Chem. Soc. Rev., 2015, 44, 943–969; (b) M. O.
Senge, Chem. Commun., 2011, 47, 1943–1960; (c) T. Tanaka, B. S. Lee,
N. Aratani, M.-C. Yoon, D. Kim, A. Osuka, Chem. Eur. J., 2011, 17,
14400–14412; (d) N. Aratani, D. Kim, A. Osuka, Acc. Chem. Res., 2009,
42, 1922–1934.
methylphenyl)-15-phenylporphyrinato]zinc(II) (41) (58 mg, 0.083
mmol), K3PO4 (200 mg, 0.50 mmol), Pd(PPh3)4 (20 mg, 8.4 μmol).
Reaction mixture was heated at 100 °C for 12 h. The crude
reaction mixture was purified using silica gel column
chromatography, desired compound was eluted via using CH2Cl2:
(CH3)2CO, 8:2. Yield = 34 mg, 60%; m.p = 331 °C; Rf = 0.2 (SiO2,
CH2Cl2:EtOAc, 8:2, v/v); 1H NMR (600 MHz, CDCl3) δ = 8.92–8.85
(m, 16H), 8.25 (t, J = 7.6 Hz, 8H), 8.11 (d, J = 7.7 Hz, 8H), 8.03
(d, J = 7.9 Hz, 4H), 7.81–7.76 (m, 6H), 7.66 (s, 2H), 7.59 (d, J =
7.7 Hz, 8H), 2.77 (s, 6H), 2.74 (s, 12H), -2.74 (s, 4H) ppm; 13C
NMR (151 MHz, CDCl3) δ = 167.4, 144.2, 142.2, 139.3, 139.2,
138.8, 137.4, 136.9, 135.2, 134.5, 134.5, 127.4, 126.6, 120.3,
[2]
(a) S. Prathapan, T. E. Johnson, J. S. Lindsey, J. Am. Chem. Soc., 1993,
115, 7519–7520; (b) R. Paolesse, R. K. Pandey, T. P. Forsyth, l.
Jaquinod, K. R. Gerzevske, D. J. Nurco, M. O. Senge, S. Licoccia, T.
Boschi, K. M. Smith, J. Am. Chem. Soc., 1996, 118, 3869–2882; (c) M.
O. Senge, W. W. Kalisch, K. Ruhlandt-Senge, Chem. Commun., 1996,
2149–2150; (d) P. S. Bols, H. L. Anderson, Acc. Chem. Res., 2018, 51,
2083–2092.
[3]
(a) A. Tsuda, A. Osuka, Science, 2001, 293, 79–82; (b) N. K. S. Davis,
A. L. Thompson, H. L. Anderson, J. Am. Chem. Soc., 2011, 133, 30–31;
(c) M. O. Senge, X. Feng, Tetrahedron Lett., 1999, 40, 4165–4168; (d)
W. Auwärter, D. Écija, F. Klappenberger, J. V. Barth, Nat. Chem., 2015,
7, 105–120.
120.1, 119.1, 118.1, 52.4, 42.0, 21.6 ppm; IR (neat)/cm-1: ν
̃ = 2981
(w), 2832 (w), 1710 (m), 1595 (m), 1367 (w), 1219 (m), 1140 (m),
1093 (m), 1047 (m), 942 (m), 807 (s), 757 (s), 691 (m), 652 (m);
UV-Vis (CHCl3): λmax (log ε) = 423 (5.92), 519 (4.52), 555 (4.25),
594 nm (4.04), 651 nm (4.06); HRMS(MALDI-TOF): m/z = calc.
for C99H75N10O2 [M+H]+ 1434.5996; 1435.6091 found.
[4]
[5]
(a) K. F. Biegasiewicz, J. R. Griffiths, G. P. Savage, J. Tsanaktsidis, R.
Priefer, Chem. Rev., 2015, 115, 6719–6745; (b) M. D. Levin, P.
Kaszynski, J. Michl, Chem. Rev., 2000, 100, 169–234.
(a) P. E. Eaton, Angew. Chem. Int. Ed., 1992, 31, 1421–1436; (b) B. A.
Chalmers, H. Xing, S. Houston, C. Clark, S. Ghassabian, A. Kuo, B. Cao,
A. Reitsma, C. P. Murray, J. E. Stok, G. M. Boyle, C. J. Pierce, S. W.
Littler, D. A. Winkler, P. V. Bernhardt, C. Pasay, J. J. De Voss, J.
McCarthy, P. G. Parsons, G. H. Walter, M. T. Smith, H. M. Cooper, S. K.
Nilsson, J. Tsanaktsidis, G. P. Savage, C. M. Williams, Angew. Chem.
Int. Ed., 2016, 55, 3580–3585.
N1,N3-Bis[3′-{(10″,15″,20″-triphenylporphyrinato)zinc(II)-5″-
yl}-phenyl]bicyclo[1.1.1]pentane-1,3-dicarboxamides
(52).
Synthesized according to General Procedure 5 using BCP 39 (19
mg, 0.033 mmol), [5-(4′,4′,5′,5′-tetramethyl-1′,3′,2′-dioxaborolan-
2′-yl)-10,20-bis(4′-methylphenyl)-15-phenylporphyrinato]zinc(II)
(41) (50 mg, 0.066 mmol), K3PO4 (70 mg, 0.33 mmol) and
Pd(PPh3)4 (0.0066 mmol, 7.6 mg). Reaction mixture was heated
at 100 °C for 4 h. The crude reaction mixture was subjected to
silica gel column chromatography and titled compound was eluted
via CH2Cl2:EtOAc, 9:1. Yield = 37 mg, 73%; m.p = 220 °C; Rf =
0.35 (SiO2, CH2Cl2:EtOAc, 8:2, v/v); 1H NMR (400 MHz,
CDCl3/CD3OD) δ = 8.85–8.81 (m, 16H), 8.32(brs, 2H), 8.17 (d, J
= 4.3 Hz, 4H), 8.03 (d, J = 7.1 Hz, 10H), 7.95 (d, J = 7.6 Hz, 2H),
7.71–7.62 (m, 8H), 7.47 (d, J = 7.2 Hz, 8H), 2.65 (s, 12H), 2.44 (s,
6H) ppm; 13C NMR (101 MHz, CDCl3/CD3OD) δ = 150.1, 149.9,
149.7, 144.1, 140.3, 136.7, 134.4, 131.5, 131.4, 131.2, 127.0,
[6]
[7]
A. M. Dilmaç, E. Spuling, A. de Meijere, S. Bräse, Angew. Chem. Int. Ed.,
2017, 56, 5684–5718.
(a) G. M. Locke, S. S. R. Bernhard, M. O. Senge, Chem. Eur. J., 2019,
25, 4590–4647; (b) P. K. Mykhailiuk, Org. Biomol. Chem., 2019, 17,
2839–2849.
[8]
(a) T. A. Reekie, C. M. Williams, L. M. Rendina, M. Kassiou, J. Med.
Chem., 2019, 62, 1078–1095; (b) N. D. Measom, K. D. Down, D. J. Hirst,
C. Jamieson, E. S. Manas, V. K. Patel, D. O. Somers, ACS Med. Chem.
Lett., 2017, 8, 43–48; (c) Y. L. Goh, Y. T. Cui, V. Pendharkar, V. A.
Adsool, ACS Med. Chem. Lett., 2017, 8, 516−520; (d) K. C. Nicolaou, J.
Yin, D. Mandal, R. D. Erande, P. Klahn, M. Jin, M. Aujay, J. Sandoval, J.
Gavrilyuk, D. Vourloumis, J. Am. Chem. Soc., 2016, 138, 1698−1708.
(a) A. R.-Fortea, J. Kaleta, C. Mézière, M. Allain, E. Canadell, P. Wzietek,
J. Michl, P. Batail, ACS Omega, 2018, 3, 1293−1297; (b) K. J. Flanagan,
S. S. R. Bernhard, S. Plunkett, M. O. Senge, Chem. Eur. J., 2019, 25,
6941−6954.
[9]
126.6, 126.2, 120.0, 52.1, 39.0, 21.3 ppm; IR (neat)/cm-1: ν
̃ = 2920
(w), 1650 (w), 1603 (w), 1518 (w), 1477 (w), 1388(w), 1204 (w),
1065 (w), 992 (s), 794 (s), 721 (m), 693 (m); UV-Vis (CHCl3): λmax
(log ε) = 422 (6.80), 551 (5.55), 589 nm (5.08); HRMS(MALDI-
TOF): m/z calc. for C99H70N10O2Zn2 [M]+ 1562.4770; 1562.4253
found.
[10] A. de Meijere, L. Zhao, V. N. Belov, M. Bossi, M. Noltemeyer, S. W. Hell,
Chem. Eur. J., 2007, 13, 2503–2516.
[11] (a) J. M. Smith, S. J. Harwood, P. S. Baran, Acc. Chem. Res., 2018, 51,
1807–1817; (b) A. Fawcett, J. Pradeilles, Y. Wang, T. Mutsuga, E. L.
Myers, V. K. Aggarwal, Science, 2017, 357, 283–286; (c) S. S. R.
Bernhard, G. M. Locke, S. Plunkett, A. Meindl, K. J. Flanagan, M. O.
Senge, Chem. Eur. J., 2018, 24, 1026–1030.
[12] I. S. Makarov, C. E. Brocklehurst, K. Karaghiosoff, G. Koch, P. Knochel,
Angew. Chem. Int. Ed., 2017, 56, 12774–12777.
Acknowledgements
[13] (a) J. Wlochal, R. D. M. Davies, J. Burton, Org. Lett., 2014, 16, 4094–
4097; (b) M. J. Soth, G. Liu, K. Le, J. Cross, J. Philip (Board of regents,
the university of Texas system) US Patent WO 2018/107072 A1.
[14] (a) A. Graul, J. Castaner, Drugs Future, 1997, 22, 956–968; (b) R. B.
Merrifield, J. Am. Chem. Soc., 1963, 85, 2149–2154; (c) J. W. Bode, Curr.
Opin. Drug Disc. Dev., 2006, 9, 765–775.
This work was supported by grants from the Science Foundation
Ireland (SFI IvP 13/IA/1894), Irish Research Council
(GOIPG/2015/3700), the Ireland-Canada University Foundation
(M.H.R.B., Dobbin Atlantic Scholarship), and through an August-
Wilhelm Scheer Gastprofessor award (M.O.S., TUM).
[15] E. Valeur, M. Bradley, Chem. Soc. Rev., 2009, 38, 606–631.
[16] W. J. Kruper, T. A. Chamberlin, M. Kochanny, J. Org. Chem., 1989, 54,
2753–2756.
This article is protected by copyright. All rights reserved.